Revance Therapeutics, Inc. - COM (RVNC)

Q2 2019 13F Holders as of 6/30/2019

Type / Class
Equity / COM
Number of holders
111
Total Shares
43.6M
Shares change
+2.08M
Total reported value, excl. options
$564M
Value change
+$26.8M
Put/Call ratio
1.87
Number of buys
62
Number of sells
-40
Price
$12.97
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.